These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12552955)

  • 1. Neoadjuvant chemotherapy for intermediate/high-grade soft tissue sarcomas: five-year results with epirubicin and ifosfamide.
    Ottaiano A; De Chiara A; Fazioli F; De Rosa V; Ravo V; Boccia V; Botti G; Petrillo A; Fiore F; Mori S; Mozzillo N; Iaffaioli VR; Apice G
    Anticancer Res; 2002; 22(6B):3555-9. PubMed ID: 12552955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
    Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas.
    Ryan CW; Montag AG; Hosenpud JR; Samuels B; Hayden JB; Hung AY; Mansoor A; Peabody TD; Mundt AJ; Undevia S
    Cancer; 2008 Jun; 112(11):2432-9. PubMed ID: 18348295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
    Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
    Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
    Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
    Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
    Meric F; Hess KR; Varma DG; Hunt KK; Pisters PW; Milas KM; Patel SR; Benjamin RS; Plager C; Papadopoulos NE; Burgess MA; Pollock RE; Feig BW
    Cancer; 2002 Sep; 95(5):1120-6. PubMed ID: 12209699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
    In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
    J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy for pulmonary metastases of soft tissue sarcoma].
    Kito M; Umeda T
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1701-6. PubMed ID: 9757195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
    Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
    Stahl R; Wang T; Lindner LH; Abdel-Rahman S; Santl M; Reiser MF; Issels RD
    Int J Hyperthermia; 2009 Jun; 25(4):289-98. PubMed ID: 19670096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of neoadjuvant chemotherapy in intermediate/high-grade soft-tissue sarcomas in the adult].
    Mori S; Apice G; Ottaiano A; De Chiara A; Germano A; Botti G; De Rosa V; Ravo V; Morrica B; Mozzillo N
    Tumori; 2003; 89(4 Suppl):267-8. PubMed ID: 12903615
    [No Abstract]   [Full Text] [Related]  

  • 16. Preoperative doxorubicin plus ifosfamide in primary soft-tissue sarcomas of the extremities.
    Azzarelli A; Quagliuolo V; Casali P; Fissi S; Montalto F; Santoro A
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S210-2. PubMed ID: 8453700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
    Harstrick A; Bokemeyer C; Schmoll HJ; Köhne-Wömpner CH; Knipp H; Schöffski P; Anagnou J; Wipperman B; Neumann S; Poliwoda H
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S217-21. PubMed ID: 8453702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
    Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
    Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal doxorubicin with and without TNFalpha in the perfusional treatment of advanced soft tissue limb sarcoma: preliminary results.
    Di Filippo F; Anzà M; Garinei R; Cavaliere F; Perri P; Botti C; Di Angelo P; Di Filippo S; Maini CL; Pasqualoni R; Di Segni S; Colantonio S; Bruno P; Piarulli L; Principi F
    In Vivo; 2006; 20(6A):735-8. PubMed ID: 17203757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma].
    Chen LK; Xu GC; Teng XY; Liang Y; Liu JL; Zhou XM
    Ai Zheng; 2002 Aug; 21(8):903-6. PubMed ID: 12478904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.